BIOLUX P-III All-Comers Passeo-18 Lux Registry

计划入组 880 人 · 首次发布于 2014 年 10 月 28 日

Post-market Registry to Assess the Clinical Performance and Safety of the Passeo-18 Lux in Infrainguinal Arteries

计划入组 200 人 · 首次发布于 2022 年 1 月 4 日

BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries

计划入组 72 人 · 首次发布于 2013 年 6 月 4 日

GS-18

DP-18

GZR-18

Lux Biosciences, Inc.

United States

Simcha Il 18, Inc.

United States

SUCCESSFIELD LUX PTY LTD

Australia

SirPAD: Sirolimus-Coated Balloons Cut Amputation and Revascularization in Infrainguinal PAD

Vabysmo Shows Vision Improvement in Underrepresented DME Populations in ELEVATUM Study

Benitec BioPharma's Gene Therapy Shows Promising Results in Oculopharyngeal Muscular Dystrophy Trial